Hans-Peter Kiem

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 50

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Asim Saha, Rahul Palchaudhuri, Leanne Lanieri, Sharon Hyzy, Megan J Riddle, Jamie Panthera, Cindy R Eide, Jakub Tolar, Angela Panoskaltsis-Mortari, Lev Gorfinkel, Victor Tkachev, Ulrike Gerdemann, Francesca Alvarez Calderon, Elisa Rojas Palato, Margaret L MacMillan, John E Wagner, Leslie S Kean, Mark J Osborn, Hans-Peter Kiem, David T Scadden, Lisa M Olson, Bruce R Blazar
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate-conditioned Fanconi anemia mice. Blood 143 (21) (2024)
Asim Saha, Rahul Palchaudhuri, Leanne Lanieri, Sharon Hyzy, Megan J Riddle, Jamie Panthera, Cindy R Eide, Jakub Tolar, Angela Panoskaltsis-Mortari, Lev Gorfinkel, Victor Tkachev, Ulrike Gerdemann, Francesca Alvarez Calderon, Elisa Rojas Palato, Margaret L MacMillan, John E Wagner, Leslie S Kean, Mark Osborn, Hans-Peter Kiem, David T Scadden, Lisa M Olson, Bruce R Blazar
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate conditioned Fanconi anemia mice. Blood (2024)
Asim Saha, Rahul Palchaudhuri, Leanne Lanieri, Sharon Hyzy, Megan J Riddle, Jamie Panthera, Cindy R Eide, Jakub Tolar, Angela Panoskaltsis-Mortari, Lev Gorfinkel, Victor Tkachev, Ulrike Gerdemann, Francesca Alvarez Calderon, Elisa Rojas Palato, Margaret L MacMillan, John E Wagner, Leslie S Kean, Mark Osborn, Hans-Peter Kiem, David T Scadden, Lisa M Olson, Bruce R Blazar
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate conditioned Fanconi anemia mice. Blood (2024)
Seunga Choo, Carl B Wolf, Heather M Mack, Mitchell J Egan, Hans-Peter Kiem, Stefan Radtke
Choosing the right mouse model: comparison of humanized NSG and NBSGW mice for in vivo HSC gene therapy. Blood advances 8 (4) (2024)
Christopher J Nicolai, Maura H Parker, Jim Qin, Weiliang Tang, Justin T Ulrich-Lewis, Rebecca J Gottschalk, Sara E Cooper, Susana A Hernandez Lopez, Don Parrilla, Richard S Mangio, Nolan G Ericson, Alissa H Brandes, Saluwa Umuhoza, Kathryn R Michels, Mollie M McDonnell, Lisa Y Park, Seungjin Shin, Wai-Hang Leung, Andrew M Scharenberg, Hans-Peter Kiem, Ryan P Larson, Laurie O Beitz, Byoung Y Ryu
In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligand. Blood 144 (9) (2024)
Asim Saha, Rahul Palchaudhuri, Leanne Lanieri, Sharon Hyzy, Megan J Riddle, Jamie Panthera, Cindy R Eide, Jakub Tolar, Angela Panoskaltsis-Mortari, Lev Gorfinkel, Victor Tkachev, Ulrike Gerdemann, Francesca Alvarez Calderon, Elisa Rojas Palato, Margaret L MacMillan, John E Wagner, Leslie S Kean, Mark Osborn, Hans-Peter Kiem, David T Scadden, Lisa M Olson, Bruce R Blazar
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate conditioned Fanconi anemia mice. Blood (2024)
Chang Li, Anna K Anderson, Peter Ruminski, Michael Rettig, Darja Karpova, Hans-Peter Kiem, John F DiPersio, André Lieber
A simplified G-CSF-free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model. Blood advances 8 (15) (2024)
Asim Saha, Rahul Palchaudhuri, Leanne Lanieri, Sharon Hyzy, Megan J Riddle, Jamie Panthera, Cindy R Eide, Jakub Tolar, Angela Panoskaltsis-Mortari, Lev Gorfinkel, Victor Tkachev, Ulrike Gerdemann, Francesca Alvarez Calderon, Elisa Rojas Palato, Margaret L MacMillan, John E Wagner, Leslie S Kean, Mark J Osborn, Hans-Peter Kiem, David T Scadden, Lisa M Olson, Bruce R Blazar
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate-conditioned Fanconi anemia mice. Blood 143 (21) (2024)
Chang Li, Anna K Anderson, Peter Ruminski, Michael Rettig, Darja Karpova, Hans-Peter Kiem, John F DiPersio, André Lieber
A simplified G-CSF-free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model. Blood advances 8 (15) (2024)
Christopher James Nicolai, Maura Parker, Jim Qin, Weiliang Tang, Justin Theophilus Ulrich-Lewis, Rebecca Gottschalk, Sara Cooper, Susana A Hernandez Lopez, Don Parrilla, Richard Mangio, Nolan Ericson, Alissa Brandes, Saluwa Umuhoza, Kathryn R Michels, Mollie M McDonnell, Lisa Y Park, Seungjin Shin, Wai-Hang Leung, Andrew Scharenberg, Hans-Peter Kiem, Ryan Peter Larson, Laurie Beitz, Byoung Ryu
In vivo CAR T-cell generation in non-human primates using lentiviral vectors displaying a multi-domain fusion ligand. Blood (2024)
Chang Li, Anna Kate Anderson, Peter G Ruminski, Michael P Rettig, Darja Karpova, Hans-Peter Kiem, John F DiPersio, André Lieber
A simplified, G-CSF-free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model. Blood advances (2024)
Christopher J Nicolai, Maura H Parker, Jim Qin, Weiliang Tang, Justin T Ulrich-Lewis, Rebecca J Gottschalk, Sara E Cooper, Susana A Hernandez Lopez, Don Parrilla, Richard S Mangio, Nolan G Ericson, Alissa H Brandes, Saluwa Umuhoza, Kathryn R Michels, Mollie M McDonnell, Lisa Y Park, Seungjin Shin, Wai-Hang Leung, Andrew M Scharenberg, Hans-Peter Kiem, Ryan P Larson, Laurie O Beitz, Byoung Y Ryu
In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligand. Blood 144 (9) (2024)
Rahul Banerjee, Christina Poh, Alexandre V Hirayama, Jordan Gauthier, Ryan D Cassaday, Mazyar Shadman, Andrew J Cowan, Brian G Till, Damian J Green, Hans-Peter Kiem, Ajay K Gopal, David G Maloney
Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinic. Blood advances 8 (4) (2024)
Seunga Choo, Carl B Wolf, Heather M Mack, Mitchell J Egan, Hans-Peter Kiem, Stefan Radtke
Choosing the right mouse model: comparison of humanized NSG and NBSGW mice for in vivo HSC gene therapy. Blood advances 8 (4) (2024)
Asim Saha, Rahul Palchaudhuri, Leanne Lanieri, Sharon Hyzy, Megan J Riddle, Jamie Panthera, Cindy R Eide, Jakub Tolar, Angela Panoskaltsis-Mortari, Lev Gorfinkel, Victor Tkachev, Ulrike Gerdemann, Francesca Alvarez Calderon, Elisa Rojas Palato, Margaret L MacMillan, John E Wagner, Leslie S Kean, Mark Osborn, Hans-Peter Kiem, David T Scadden, Lisa M Olson, Bruce R Blazar
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate conditioned Fanconi anemia mice. Blood (2024)
Rahul Banerjee, Christina Poh, Alexandre V Hirayama, Jordan Gauthier, Ryan D Cassaday, Mazyar Shadman, Andrew J Cowan, Brian G Till, Damian J Green, Hans-Peter Kiem, Ajay K Gopal, David G Maloney
Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinic. Blood advances 8 (4) (2024)
Chang Li, Anna Kate Anderson, Peter G Ruminski, Michael P Rettig, Darja Karpova, Hans-Peter Kiem, John F DiPersio, André Lieber
A simplified, G-CSF-free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model. Blood advances (2024)
Rahul Banerjee, Christina Poh, Alexandre V Hirayama, Jordan Gauthier, Ryan D Cassaday, Mazyar Shadman, Andrew J Cowan, Brian G Till, Damian J Green, Hans-Peter Kiem, Ajay K Gopal, David G Maloney
Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinic. Blood advances (2024)
Asim Saha, Rahul Palchaudhuri, Leanne Lanieri, Sharon Hyzy, Megan J Riddle, Jamie Panthera, Cindy R Eide, Jakub Tolar, Angela Panoskaltsis-Mortari, Lev Gorfinkel, Victor Tkachev, Ulrike Gerdemann, Francesca Alvarez Calderon, Elisa Rojas Palato, Margaret L MacMillan, John E Wagner, Leslie S Kean, Mark Osborn, Hans-Peter Kiem, David T Scadden, Lisa M Olson, Bruce R Blazar
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate conditioned Fanconi anemia mice. Blood (2024)
Chang Li, Anna K Anderson, Peter Ruminski, Michael Rettig, Darja Karpova, Hans-Peter Kiem, John F DiPersio, André Lieber
A simplified G-CSF-free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model. Blood advances 8 (15) (2024)
Asim Saha, Rahul Palchaudhuri, Leanne Lanieri, Sharon Hyzy, Megan J Riddle, Jamie Panthera, Cindy R Eide, Jakub Tolar, Angela Panoskaltsis-Mortari, Lev Gorfinkel, Victor Tkachev, Ulrike Gerdemann, Francesca Alvarez Calderon, Elisa Rojas Palato, Margaret L MacMillan, John E Wagner, Leslie S Kean, Mark J Osborn, Hans-Peter Kiem, David T Scadden, Lisa M Olson, Bruce R Blazar
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate-conditioned Fanconi anemia mice. Blood 143 (21) (2024)
Chang Li, Anna K Anderson, Peter Ruminski, Michael Rettig, Darja Karpova, Hans-Peter Kiem, John F DiPersio, André Lieber
A simplified G-CSF-free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model. Blood advances 8 (15) (2024)
Asim Saha, Rahul Palchaudhuri, Leanne Lanieri, Sharon Hyzy, Megan J Riddle, Jamie Panthera, Cindy R Eide, Jakub Tolar, Angela Panoskaltsis-Mortari, Lev Gorfinkel, Victor Tkachev, Ulrike Gerdemann, Francesca Alvarez Calderon, Elisa Rojas Palato, Margaret L MacMillan, John E Wagner, Leslie S Kean, Mark J Osborn, Hans-Peter Kiem, David T Scadden, Lisa M Olson, Bruce R Blazar
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate-conditioned Fanconi anemia mice. Blood 143 (21) (2024)
Seunga Choo, Carl B Wolf, Heather M Mack, Mitchell J Egan, Hans-Peter Kiem, Stefan Radtke
Choosing the right mouse model: comparison of humanized NSG and NBSGW mice for in vivo HSC gene therapy. Blood advances 8 (4) (2024)
Seunga Choo, Carl B Wolf, Heather M Mack, Mitchell J Egan, Hans-Peter Kiem, Stefan Radtke
Choosing the right mouse model: comparison of humanized NSG and NBSGW mice for in vivo HSC gene therapy. Blood advances (2023)
Florence Borot, Olivier Humbert, Gregory A Newby, Emily Fields, Sajeev Kohli, Stefan Radtke, George S Laszlo, Thiyagaraj Mayuranathan, Abdullah Mahmood Ali, Mitchell J Weiss, Jonathan S Yen, Roland B Walter, David R Liu, Siddhartha Mukherjee, Hans-Peter Kiem
Multiplex Base Editing to Protect from CD33-Directed Therapy: Implications for Immune and Gene Therapy. bioRxiv : the preprint server for biology (2023)
Stefan Radtke, Mark R Enstrom, Dnyanada Pande, Elizabeth R Duke, Erwing Fabian Cardozo Ojeda, Ravishankar Madhu, Staci Owen, Greta Kanestrom, Margaret Lee Cui, Anai M Perez, Joshua T Schiffer, Hans-Peter Kiem
Stochastic fate decisions of HSCs after transplantation: early contribution, symmetric expansion, and pool formation. Blood (2023)
Chang Li, Aphrodite Georgakopoulou, Gregory A Newby, Peter J Chen, Kelcee A Everette, Kiriaki Paschoudi, Efthymia Vlachaki, Sucheol Gil, Anna K Anderson, Theodore Koob, Lishan Huang, Hongjie Wang, Hans-Peter Kiem, David R Liu, Evangelia Yannaki, André Lieber
In vivo HSC prime editing rescues Sickle Cell Disease in a mouse model. Blood (2023)
Emily C Liang, Aya Albittar, Jennifer J Huang, Alexandre V Hirayama, Erik L Kimble, Andrew J Portuguese, Aude G Chapuis, Mazyar Shadman, Brian G Till, Ryan D Cassaday, Filippo Milano, Hans-Peter Kiem, Stanley R Riddell, Cameron J Turtle, David G Maloney, Jordan Gauthier
Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL. Blood advances (2023)
Alexandre V Hirayama, Erik L Kimble, Jocelyn H Wright, Salvatore Fiorenza, Jordan Gauthier, Jenna M Voutsinas, Qian Vicky Wu, Cecilia C S Yeung, Nicolas Gazeau, Barbara S Pender, Delaney R Kirchmeier, Aiko Torkelson, Abigail Chutnik, Ryan D Cassaday, Aude G Chapuis, Damian J Green, Hans-Peter Kiem, Filippo Milano, Mazyar Shadman, Brian G Till, Stanley R Riddell, David G Maloney, Cameron J Turtle
Timing of Anti-PD-L1 Antibody Initiation Affects Efficacy/Toxicity of CD19 CAR-T Cell Therapy for Large B-Cell Lymphoma. Blood advances (2023)
Daniel Stone, Nadja Meumann, Anne-Sophie Kuhlmann, Christopher W Peterson, Hong Xie, Pavitra Roychoudhury, Michelle A Loprieno, Xuan-Khang Vu, Daniel E Strongin, Elizabeth J Kenkel, Anoria Haick, Laurence Stensland, Willimark M Obenza, Jacob Parrott, Veronica Nelson, Robert D Murnane, Meei-Li W Huang, Martine Aubert, Hans-Peter Kiem, Hildegard Büning, Keith R Jerome
A multiplexed barcode approach to simultaneously evaluate gene delivery by adeno-associated virus capsid variants in nonhuman primates. Hepatology communications 7 (2) (2023)
Khrystyna North, Salima Benbarche, Bo Liu, Joseph Pangallo, Sisi Chen, Maximilian Stahl, Jan Philipp Bewersdorf, Robert F Stanley, Caroline Erickson, Hana Cho, Jose Mario Bello Pineda, James D Thomas, Jacob T Polaski, Andrea E Belleville, Austin M Gabel, Dylan B Udy, Olivier Humbert, Hans-Peter Kiem, Omar Abdel-Wahab, Robert K Bradley
Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells. Nature biotechnology 40 (7) (2022)
Stefan Radtke, Dnyanada Pande, Mark R Enstrom, Hans-Peter Kiem
Safe and efficient lentiviral vector integration with HSC-targeted gene therapy. Blood advances (2022)
Hongjie Wang, Audrey Germond, Chang Li, Sucheol Gil, Jiho Kim, Hans-Peter Kiem, André Lieber
In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4. Blood advances 6 (15) (2022)
Asim Saha, Sharon Hyzy, Tahirih Lamothe, Katelyn Hammond, Nicholas Clark, Leanne Lanieri, Prashant Bhattarai, Rahul Palchaudhuri, Geoffrey O Gillard, Jennifer Proctor, Megan J Riddle, Angela Panoskaltsis-Mortari, Margaret L MacMillan, John E Wagner, Hans-Peter Kiem, Lisa M Olson, Bruce R Blazar
A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in mice. Blood 139 (11) (2022)
Hongjie Wang, Chang Li, Adebimpe O Obadan, Hannah Frizzell, Tien-Ying Hsiang, Sucheol Gil, Audrey Germond, Connie Fountain, Audrey Baldessari, Steve Roffler, Hans-Peter Kiem, Deborah H Fuller, André Lieber
In Vivo Hematopoietic Stem Cell Gene Therapy for SARS-CoV2 Infection Using a Decoy Receptor. Human gene therapy 33 (7-8) (2022)
Colin D Godwin, George S Laszlo, Salvatore Fiorenza, Eliotte E Garling, Tinh-Doan Phi, Olivia M Bates, Colin E Correnti, Benjamin G Hoffstrom, Margaret C Lunn-Halbert, Olivier Humbert, Hans-Peter Kiem, Cameron J Turtle, Roland Bruno Walter
Targeting the membrane-proximal C2-set domain of CD33 for improved CD33-directed immunotherapy. Leukemia 35 (9) (2021)
Trisha R Berger, Stefan Radtke, Tayla M Olsen, Hans-Peter Kiem, Anthony Rongvaux
Human hematopoietic stem cell maintenance and myeloid cell development in next-generation humanized mouse models. Blood advances 3 (3) (2020)
Olivier Humbert, Clare Samuelson, Hans-Peter Kiem
CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside. British journal of haematology 192 (1) (2020)
Olivier Humbert, Stefan Radtke, Clare Samuelson, Ray R Carrillo, Anai M Perez, Sowmya S Reddy, Christopher Lux, Sowmya Pattabhi, Lauren E Schefter, Olivier Negre, Ciaran M Lee, Gang Bao, Jennifer E Adair, Christopher W Peterson, David J Rawlings, Andrew M Scharenberg, Hans-Peter Kiem
Therapeutically relevant engraftment of a CRISPR-Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates. Science translational medicine 11 (503) (2020)
Colin D Godwin, George S Laszlo, Brent L Wood, Colin E Correnti, Olivia M Bates, Eliotte E Garling, Zhengwei J Mao, Mary E Beddoe, Margaret C Lunn, Olivier Humbert, Hans-Peter Kiem, Roland B Walter
The CD33 splice isoform lacking exon 2 as therapeutic target in human acute myeloid leukemia. Leukemia 34 (9) (2020)
Alyssa Sheih, Valentin Voillet, Laïla-Aïcha Hanafi, Hannah A DeBerg, Masanao Yajima, Reed Hawkins, Vivian H Gersuk, Stanley R Riddell, David G Maloney, Martin E Wohlfahrt, Dnyanada Pande, Mark R Enstrom, Hans-Peter Kiem, Jennifer E Adair, Raphaël Gottardo, Peter S Linsley, Cameron J Turtle
Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy. Nature communications 11 (1) (2020)
Alexandre V Hirayama, Jordan Gauthier, Kevin Anthony Hay, Jenna M Voutsinas, Qian Wu, Ted Gooley, Daniel Li, Sindhu Cherian, Xueyan Chen, Barbara S Pender, Reed M Hawkins, Aesha Vakil, Rachel N Steinmetz, Utkarsh H Acharya, Ryan D Cassaday, Aude G Chapuis, Tejaswini M Dhawale, Paul C Hendrie, Hans-Peter Kiem, Ryan C Lynch, Jorge Ramos, Mazyar Shadman, Brian G Till, Stanley R Riddell, David G Maloney, Cameron J Turtle
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells. Blood 133 (17) (2019)
Kevin Anthony Hay, Jordan Gauthier, Alexandre V Hirayama, Jenna M Voutsinas, Qian Vicky Wu, Daniel Li, Theodore A Gooley, Sindhu Cherian, Xueyan Chen, Barbara S Pender, Reed M Hawkins, Aesha Vakil, Rachel N Steinmetz, Gary Schoch, Aude G Chapuis, Brian G Till, Hans-Peter Kiem, Jorge D Ramos, Mazyar Shadman, Ryan D Cassaday, Utkarsh H Acharya, Stanley R Riddell, David G Maloney, Cameron J Turtle
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy. Blood 133 (15) (2019)
Kevin G Haworth, Christina Ironside, Megan A Ramirez, Sarah Weitz, Brian C Beard, Jonathan D Schwartz, Jennifer E Adair, Hans-Peter Kiem
Minimal conditioning in Fanconi anemia promotes multi-lineage marrow engraftment at 10-fold lower cell doses. The journal of gene medicine 20 (10-11) (2018)
Stefan Radtke, Jennifer E Adair, Morgan A Giese, Yan-Yi Chan, Zachary K Norgaard, Mark R Enstrom, Kevin G Haworth, Lauren E Schefter, Hans-Peter Kiem
A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates. Science translational medicine 9 (414) (2018)
Christopher W Peterson, Jianbin Wang, Claire Deleage, Sowmya Reddy, Jasbir Kaur, Patricia Polacino, Andreas Reik, Meei-Li Huang, Keith R Jerome, Shiu-Lok Hu, Michael C Holmes, Jacob D Estes, Hans-Peter Kiem
Differential impact of transplantation on peripheral and tissue-associated viral reservoirs: Implications for HIV gene therapy. PLoS pathogens 14 (4) (2018)
Lucrezia Colonna, Christopher W Peterson, John B Schell, Judith M Carlson, Victor Tkachev, Melanie Brown, Alison Yu, Sowmya Reddy, Willi M Obenza, Veronica Nelson, Patricia S Polacino, Heather Mack, Shiu-Lok Hu, Katie Zeleski, Michelle Hoffman, Joe Olvera, Scott N Furlan, Hengqi Betty Zheng, Agne Taraseviciute, Daniel J Hunt, Kayla Betz, Jennifer F Lane, Keith Vogel, Charlotte E Hotchkiss, Cassie Moats, Audrey Baldessari, Robert D Murnane, Christopher English, Cliff A Astley, Solomon Wangari, Brian Agricola, Joel Ahrens, Naoto Iwayama, Andrew May, Laurence Stensland, Meei-Li W Huang, Keith R Jerome, Hans-Peter Kiem, Leslie S Kean
Evidence for persistence of the SHIV reservoir early after MHC haploidentical hematopoietic stem cell transplantation. Nature communications 9 (1) (2018)
Olivier Humbert, George S Laszlo, Sophie Sichel, Christina Ironside, Kevin G Haworth, Olivia M Bates, Mary E Beddoe, Ray R Carrillo, Hans-Peter Kiem, Roland Bruno Walter
Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR/Cas9-deletion of CD33 exon 2. Leukemia 33 (3) (2018)
Anjie Zhen, Christopher W Peterson, Mayra A Carrillo, Sowmya Somashekar Reddy, Cindy S Youn, Brianna B Lam, Nelson Y Chang, Heather A Martin, Jonathan W Rick, Jennifer Kim, Nick C Neel, Valerie K Rezek, Masakazu Kamata, Irvin S Y Chen, Jerome A Zack, Hans-Peter Kiem, Scott G Kitchen
Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS. PLoS pathogens 13 (12) (2017)

Hans-Peter Kiem.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hans-Peter Kiem